CT
BMY icon

Chicago Trust’s Bristol-Myers Squibb BMY Stock Holding History

Chicago Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
44,250
+3,520
+9% +$202K 0.37% 60
2026
Q1 		$2.47M Buy
40,730
+3,567
+10% +$208K 0.39% 58
2025
Q4 		$2M Buy
37,163
+14,556
+64% +$700K 0.31% 70
2025
Q3 		$1.02M Buy
22,607
+2,704
+14% +$126K 0.14% 131
2025
Q2 		$921K Sell
19,903
-10,191
-34% -$500K 0.13% 146
2025
Q1 		$1.84M Buy
30,094
+7,890
+36% +$460K 0.33% 75
2024
Q4 		$1.26M Buy
22,204
+3,270
+17% +$183K 0.22% 103
2024
Q3 		$980K Buy
18,934
+3,044
+19% +$143K 0.17% 125
2024
Q2 		$660K Sell
15,890
-1,805
-10% -$80.8K 0.13% 140
2024
Q1 		$960K Sell
17,695
-30
-0.2% -$1.53K 0.2% 116
2023
Q4 		$909K Sell
17,725
-6,439
-27% -$338K 0.2% 117
2023
Q3 		$1.4M Sell
24,164
-385
-2% -$23.6K 0.35% 72
2023
Q2 		$1.57M Sell
24,549
-1,972
-7% -$132K 0.38% 68
2023
Q1 		$1.84M Sell
26,521
-146
-0.5% -$10.3K 0.46% 53
2022
Q4 		$1.92M Sell
26,667
-970
-4% -$73.1K 0.48% 55
2022
Q3 		$1.96M Buy
27,637
+324
+1% +$23.5K 0.51% 49
2022
Q2 		$2.1M Buy
27,313
+396
+1% +$30.2K 0.53% 52
2022
Q1 		$1.97M Sell
26,917
-3,106
-10% -$209K 0.42% 61
2021
Q4 		$1.87M Sell
30,023
-825
-3% -$48.4K 0.37% 77
2021
Q3 		$1.82M Buy
30,848
+685
+2% +$45.1K 0.4% 69
2021
Q2 		$2.02M Buy
30,163
+13,603
+82% +$887K 0.48% 61
2021
Q1 		$1.04M Sell
16,560
-4,611
-22% -$287K 0.36% 78
2020
Q4 		$1.31M Buy
21,171
+4,469
+27% +$275K 0.45% 62
2020
Q3 		$1.01M Buy
16,702
+998
+6% +$60.1K 0.42% 68
2020
Q2 		$924K Sell
15,704
-2,091
-12% -$125K 0.41% 70
2020
Q1 		$992K Buy
17,795
+100
+0.6% +$6.11K 0.5% 57
2019
Q4 		$1.14M Buy
17,695
+70
+0.4% +$4.01K 0.46% 60
2019
Q3 		$894K Sell
17,625
-3,387
-16% -$159K 0.38% 78
2019
Q2 		$953 Hold
21,012
– – 0.41% 68
2019
Q1 		$1K Sell
21,012
-240
-1% -$12K 0.43% 65
2018
Q4 		$1.1K Sell
21,252
-272
-1% -$14.6K 0.52% 57
2018
Q3 		$1.34M Sell
21,524
-1,310
-6% -$77.7K 0.53% 61
2018
Q2 		$1.26M Buy
22,834
+10
+0% +$540 0.54% 58
2018
Q1 		$1.44M Buy
22,824
+971
+4% +$62.5K 0.62% 56
2017
Q4 		$1.34M Sell
21,853
-100
-0.5% -$6.25K 0.54% 63
2017
Q3 		$1.4K Buy
21,953
+1,750
+9% +$102K 0.59% 60
2017
Q2 		$1.13K Sell
20,203
-628
-3% -$34.2K 0.5% 66
2017
Q1 		$1.13K Sell
20,831
-1,050
-5% -$57.6K 0.5% 64
2016
Q4 		$1.28M Sell
21,881
-4,753
-18% -$260K 0.55% 64
2016
Q3 		$1.44M Sell
26,634
-85
-0.3% -$5.46K 0.63% 63
2016
Q2 		$1.97M Buy
26,719
+1,045
+4% +$73.8K 0.81% 47
2016
Q1 		$1.64M Sell
25,674
-3,775
-13% -$238K 0.68% 55
2015
Q4 		$2.03M Sell
29,449
-1,458
-5% -$96.3K 0.79% 45
2015
Q3 		$1.83M Sell
30,907
-700
-2% -$44.4K 0.7% 48
2015
Q2 		$2.1M Sell
31,607
-2,650
-8% -$175K 0.74% 44
2015
Q1 		$2.21M Buy
+34,257
New +$2.14M 0.76% 44

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Chicago Trust's BMY Position: Q2 2026 in Review

Chicago Trust increased its Bristol-Myers Squibb (BMY) stake by 8.6% in Q2 2026, buying an estimated $202K and bringing the position to 44,250 shares worth $2.55M. The position accounts for 0.37% of the portfolio, ranked #60.

Chicago Trust first reported a position in BMY in Q1 2015 and has held it in 46 quarters since. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Chicago Trust held 44,250 shares of Bristol-Myers Squibb worth $2.55M as of Q2 2026.
  • Chicago Trust bought 3,520 Bristol-Myers Squibb shares in Q2 2026, an estimated $202K.
  • Bristol-Myers Squibb made up 0.37% of Chicago Trust's portfolio in Q2 2026, its #60 holding.
  • Chicago Trust first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 46 quarters since.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.